InterMune, Myriad battered in early action
May 05, 2010 at 10:38 AM EDT
Shares of InterMune Inc. and Myriad Genetics both hit the skids early Wednesday as the broader market retreated on continued concerns about the growing sovereign debt crisis in Europe.
